Docetaxel

Sold as Docelex, Cipla docetaxel, Eriox, Docefrez, Docetere rtu, Axtere, Accord docetaxel, Key-docetaxel and diluent, Docetaxel zydus, Taxocan, Docetaxel adco, Docetaxel teva, Docetaxel accord rtu, Docetaxel accord, Xobrest, Docetaxel iv austell, Innotere, Eurotax, Otaxec, Cedocet, Hodexel, Docetaxel hetero, Doceturas

No structure available

This product's active ingredient could not be matched to a single known compound.

Loading Wikipedia summary

Registration

Applicants: 15
Registrations: 53
Schedule source: Consolidated Schedules 06 July 2026

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Cipla Medpro (Pty) LtdCertificate held by CiplaCancelled	Docelex, Cipla docetaxel	20, 80	410158, 410159, 410162, 410163	S4	PI PIL
Eurolab (Pty) LtdCertificate held by Eurolab	Eriox, Eurotax	20 mg, 80 mg, 140 mg	420006, 420008, 520263, 520264, 520265	S4	PI PIL
MSQ Pharma (Pty) Ltd	Docefrez	20, 80	430793, 430794	S4	None
Sanofi-aventis South Africa (Pty) LtdCancelled	Docetere rtu	20 mg/1 ml, 80 mg/4 ml	440098, 440099	S4	None
RBC Pharmaceuticals (Pty) Ltd	Axtere	20	440556	S4	None
Accord Healthcare (Pty) Ltd2 of 6 cancelled	Axtere, Accord docetaxel, Docetaxel accord rtu, Docetaxel accord	20, 80, 160	440557, 440558, 440559, 490832, 490833, 490834	S4	None
Key Oncologics (Pty) LtdCancelled	Key-docetaxel and diluent	20 mg, 80 mg	450328, 450329	S4	None
Zydus Healthcare (Pty) LtdCertificate held by Zydus Healthcare SA (Pty) Ltd	Docetaxel zydus, Taxocan	20mg / 80mg, 20, 80	460262, 460263, 460264, 460265	S4	PI PIL
Adcock Ingram Critical Care (Pty) Ltd	Docetaxel adco	20 mg/1 ml, 80 mg/4 ml, 160 mg/7 ml	460375, 460376, 460377	S4	None
Teva Pharmaceuticals (Pty) LtdCertificate held by Teva Pharmaceuticals (Pty) Ltd,	Docetaxel teva	20, 80	470940, 470941	S4	PI PIL
Austell Pharmaceuticals (Pty) LtdCancelled	Xobrest, Docetaxel iv austell	20 mg/ 1 mL, 80 mg/ 4 mL, 140 mg/ 7 mL	510273, 510274, 510275, 510276, 510277	S4	None
Innovata pharmaceuticals	Innotere	20, 80	520202, 520203	S4	None
Aurogen South Africa (Pty) Ltd	Otaxec, Cedocet	20 mg/2 ml, 80 mg/8 ml, 160 mg/16 ml	560028, 560029, 560030, 560031.028, 560032.029, 560033.030	S4	None
Hetero Drugs South Africa (Pty) Ltd	Hodexel, Docetaxel hetero	20 mg/ml, 80 mg/4 ml, 160 mg/8 ml	560756, 560757, 560758, 560759.756, 560760.757, 560761.758	S4	None
Pharma-q Holdings (Pty) Ltd	Doceturas	20 mg, 80 mg, 160 mg	570025, 570026, 570027	S4	PI PIL

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Docelex 20 EACH 5,0 ml VIAL CONTAINS DOCETAXEL 20,0 mg	20	41015841/26/0158	Cancelled	S4	None
Docelex 80 EACH VIAL CONTAINS DOCETAXEL 80,0 mg	80	41015941/26/0159	Cancelled	S4	None
Cipla docetaxel 20 EACH VIAL CONTAINS DOCETAXEL 20,0 mg	20Injection	41016241/26/0162Approved 4 March 2011	Cancelled	S4	PI PIL
Cipla docetaxel 80 EACH 5,0 ml VIAL CONTAINS DOCETAXEL 80,0 mg	80Injection	41016341/26/0163Approved 4 March 2011	Cancelled	S4	PI PIL
Eriox 20 EACH VIAL CONTAINS DOCETAXEL 20,0 mg	20Infusion. Solution	42000642/26/0006Approved 4 December 2009	Registered	S4	PI PIL
Eriox 80 EACH VIAL CONTAINS DOCETAXEL 80,0 mg	80Infusion. Solution	42000842/26/0008Approved 4 December 2009	Registered	S4	PI PIL
Docefrez 20 EACH VIAL CONTAINS DOCETAXEL 20,0 mg	20	43079343/26/0793	Registered	S4	None
Docefrez 80 EACH VIAL CONTAINS DOCETAXEL 80,0 mg	80	43079443/26/0794	Registered	S4	None
Docetere 20 mg/1 ML rtu EACH 1,0 ml SOLUTION CONTAINS DOCETAXEL 20,0 mg	20 mg/1 ml	44009844/26/0098	Cancelled	S4	None
Docetere 80 mg/4 ML rtu EACH 4,0 ml SOLUTION CONTAINS DOCETAXEL 80,0 mg	80 mg/4 ml	44009944/26/0099	Cancelled	S4	None
Axtere 20 EACH 0,5 ml VIAL CONTAINS DOCETAXEL 20,0 mg	20	44055644/26/0556	Registered	S4	None
Axtere 80 EACH 2,0 ml VIAL CONTAINS DOCETAXEL 80,0 mg	80	44055744/26/0557	Registered	S4	None
Accord docetaxel 20 EACH 0,5 ml VIAL CONTAINS DOCETAXEL 20,0 mg	20	44055844/26/0558	Cancelled	S4	None
Accord docetaxel 80 EACH 2,0 ml VIAL CONTAINS DOCETAXEL 80,0 mg	80	44055944/26/0559	Cancelled	S4	None
Key-docetaxel 20 MG and diluent solution EACH VIAL CONTAINS DOCETAXEL 20,0 mg	20 mgSolution	45032845/26/0328	Cancelled	S4	None
Key-docetaxel 80 MG and diluent solution EACH VIAL CONTAINS DOCETAXEL 80,0 mg	80 mgSolution	45032945/26/0329	Cancelled	S4	None
Docetaxel zydus 80 EACH VIAL CONTAINS DOCETAXEL 80,0 mg	20mg / 80mgSolution for infusion.	46026246/26/0262Approved 19 February 2026	Registered	S4	PI PIL
Docetaxel zydus 20 EACH VIAL CONTAINS DOCETAXEL 20,0 mg	20mg / 80mgSolution for infusion.	46026346/26/0263Approved 19 February 2026	Registered	S4	PI PIL
Taxocan 80 EACH VIAL CONTAINS DOCETAXEL 80,0 mg	80Solution for infusion	46026446/26/0264Approved 19 February 2026	Registered	S4	PI PIL
Taxocan 20 EACH VIAL CONTAINS DOCETAXEL 20,0 mg	20Solution for infusion	46026546/26/0265Approved 19 February 2026	Registered	S4	PI PIL
Docetaxel adco 20 mg/1 ML Each vial contains: Docetaxel 20,0 mg	20 mg/1 ml	46037546/26/0375	Registered	S4	None
Docetaxel adco 80 mg/4 ML EACH 4,0 ml SOLUTION CONTAINS: DOCETAXEL 80,0 mg	80 mg/4 ml	46037646/26/0376	Registered	S4	None
Docetaxel adco 160 mg/7 ML EACH 7,0 ml SOLUTION CONTAINS :DOCETAXEL 160,0 mg	160 mg/7 ml	46037746/26/0377	Registered	S4	None
Docetaxel 20 teva	20Concentrate for solution for infusion	47094047/26/0940Approved 18 June 2024	Registered	S4	PI PIL
Docetaxel 80 teva	80Concentrate for solution for infusion	47094147/26/0941Approved 18 June 2024	Registered	S4	PI PIL
Docetaxel accord 20 rtu EACH 1,0 ml VIAL CONTAINS: DOCETAXEL 20,0 mg	20	49083249/26/0832	Registered	S4	None
Docetaxel accord 80 EACH 1,0 ml VIAL CONTAINS :DOCETAXEL 80,0 mg	80	49083349/26/0833	Registered	S4	None
Docetaxel accord 160 EACH VIAL CONTAINS DOCETAXEL 160,0 mg	160	49083449/26/0834	Registered	S4	None
Xobrest 20 mg/ 1 ML EACH SINGLE DOSE VIAL (1 mL CONCENTRATE) CONTAINS: DOCETAXEL TRIHYDRATE EQUIVALENT TO DOCETAXEL ANHYDROUS 20,0 mg	20 mg/ 1 mL	51027351/26/0273	Cancelled	S4	None
Xobrest 80 mg/ 4 ML EACH SINGLE DOSE VIAL (4 mL CONCENTRATE) CONTAINS: DOCETAXEL TRIHYDRATE EQUIVALENT TO DOCETAXEL ANHYDROUS 80,0 mg	80 mg/ 4 mL	51027451/26/0274	Cancelled	S4	None
Xobrest 140 mg/ 7 ML EACH SINGLE DOSE VIAL (7 mL CONCENTRATE) CONTAINS: DOCETAXEL TRIHYDRATE EQUIVALENT TO DOCETAXEL ANHYDROUS 140,0 mg	140 mg/ 7 mL	51027551/26/0275	Cancelled	S4	None
Docetaxel iv 20 mg/ 1 ML austell EACH SINGLE DOSE VIAL (1 mL CONCENTRATE) CONTAINS: DOCETAXEL TRIHYDRATE EQUIVALENT TO DOCETAXEL ANHYDROUS 20,0 mg	20 mg/ 1 mL	51027651/26/0276	Cancelled	S4	None
Docetaxel iv 80 mg/ 4 ML austell EACH SINGLE DOSE VIAL (4 mL CONCENTRATE) CONTAINS: DOCETAXEL TRIHYDRATE EQUIVALENT TO DOCETAXEL ANHYDROUS 80,0 mg	80 mg/ 4 mL	51027751/26/0277	Cancelled	S4	None
Innotere 20 EACH 1,0 ml SOLUTION CONTAINS DOCETAXEL 20,0 mg	20	52020252/26/0202	Registered	S4	None
Innotere 80 EACH 1,0 ml SOLUTION CONTAINS DOCETAXEL 80,0 mg	80	52020352/26/0203	Registered	S4	None
Eurotax 20 MG EACH 1,0 ml SOLUTION CONTAINS: DOCETAXEL 20,0 mg	20 mg	52026352/26/0263	Registered	S4	None
Eurotax 80 MG EACH 4,0 ml SOLUTION CONTAINS: DOCETAXEL 80,0 mg	80 mg	52026452/26/0264	Registered	S4	None
Eurotax 140 MG EACH 7,0 ml SOLUTION CONTAINS: DOCETAXEL 140,0 mg	140 mg	52026552/26/0265	Registered	S4	None
Otaxec 20 mg/2 ML EACH 2,0 ml SOLUTION CONTAINS DOCETAXEL 20,0 mg	20 mg/2 ml	56002856/26/0028	Registered	S4	None
Otaxec 80 mg/8 ML EACH 8,0 ml SOLUTION CONTAINS DOCETAXEL 80,0 mg	80 mg/8 ml	56002956/26/0029	Registered	S4	None
Otaxec 160 mg/16 ML EACH 16,0 ml SOLUTION CONTAINS DOCETAXEL 160,0 mg	160 mg/16 ml	56003056/26/0030	Registered	S4	None
Cedocet 20 mg/2 ML EACH 2,0 ml SOLUTION CONTAINS DOCETAXEL 20,0 mg	20 mg/2 ml	560031.02856/26/0031.028	Registered	S4	None
Cedocet 80 mg/8 ML EACH 8,0 ml SOLUTION CONTAINS DOCETAXEL 80,0 mg	80 mg/8 ml	560032.02956/26/0032.029	Registered	S4	None
Cedocet 160 mg/16 ML EACH 16,0 ml SOLUTION CONTAINS DOCETAXEL 160,0 mg	160 mg/16 ml	560033.03056/26/0033.030	Registered	S4	None
Hodexel 20 mg/ml EACH VIAL CONTAINS DOCETAXEL 20,0 mg	20 mg/ml	56075656/26/0756	Registered	S4	None
Hodexel 80 mg/4 ML EACH VIAL CONTAINS DOCETAXEL 80,0 mg	80 mg/4 ml	56075756/26/0757	Registered	S4	None
Hodexel 160 mg/8 ML EACH VIAL CONTAINS DOCETAXEL 160,0 mg	160 mg/8 ml	56075856/26/0758	Registered	S4	None
Docetaxel 20 mg/ml hetero EACH VIAL CONTAINS DOCETAXEL 20,0 mg	20 mg/ml	560759.75656/26/0759.756	Registered	S4	None
Docetaxel 80 mg/4 ML hetero EACH VIAL CONTAINS DOCETAXEL 80,0 mg	80 mg/4 ml	560760.75756/26/0760.757	Registered	S4	None
Docetaxel 160 mg/8 ML hetero EACH VIAL CONTAINS DOCETAXEL 160,0 mg	160 mg/8 ml	560761.758	Registered	S4	None
Doceturas 20 MG EACH VIAL CONTAINS: DOCETAXEL TRIHYDRATE EQUIVALENT TO DOCETAXEL 20,0 mg	20 mgConcentrate for solution for infusion	57002557/26/0025Approved 27 August 2025	Registered	S4	PI PIL
Doceturas 80 MG EACH VIAL CONTAINS: DOCETAXEL TRIHYDRATE EQUIVALENT TO DOCETAXEL 80,0 mg	80 mgConcentrate for solution for infusion	57002657/26/0026Approved 27 August 2025	Registered	S4	PI PIL
Doceturas 160 MG EACH VIAL CONTAINS: DOCETAXEL TRIHYDRATE EQUIVALENT TO DOCETAXEL 160,0 mg	160 mgConcentrate for solution for infusion	57002757/26/0027Approved 27 August 2025	Registered	S4	PI PIL

Regulatory status

Where S4 sits on the scale

S0S1S2S3S4S5S6S7S8

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Docetaxel

S4: Docetaxel
Consolidated Schedules 06 July 2026, line 6096

Pharmacological class: Cytostatic agents (class 26)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Cipla docetaxel 20, Cipla Medpro (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsCipla docetaxel 20, Cipla Medpro (Pty) Ltd Patient information leaflet (PIL)For patients and carersCipla docetaxel 20, Cipla Medpro (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background